DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Systemic lupus erythematosus	R-HSA-977105	map05322	IC-86621	6843	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	IC-86621	6843	drug-path
Parkinson's disease	R-HSA-1643685	0	IC-86621	6843	drug-path
Natural killer cell mediated cytotoxicity	R-HSA-5218921	map04650	ramifenazone	5037	drug-path
Alzheimer's disease	R-HSA-1643685	0	ramifenazone	5037	drug-path
Huntington's disease	R-HSA-1643685	0	ramifenazone	5037	drug-path
Olfactory transduction	R-HSA-9751605	map04740	ramifenazone	5037	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	ramifenazone	5037	drug-path
Parkinson's disease	R-HSA-1643685	0	ramifenazone	5037	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	ramifenazone	5037	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	ramifenazone	5037	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	ramifenazone	5037	drug-path
Allograft rejection	R-HSA-9679028	map05330	ramifenazone	5037	drug-path
Olfactory transduction	R-HSA-9751605	map04740	bemegride	2310	drug-path
Gap junction	R-HSA-190861	map04540	bemegride	2310	drug-path
GnRH signaling pathway	R-HSA-168638	map04912	bemegride	2310	drug-path
Pathways in cancer	R-HSA-9824443	map05200	bemegride	2310	drug-path
Epithelial cell signaling in Helicobacter pylori infection	0	map05120	bemegride	2310	drug-path
Natural killer cell mediated cytotoxicity	R-HSA-5218921	map04650	valdecoxib	119607	drug-path
Alzheimer's disease	R-HSA-1643685	0	valdecoxib	119607	drug-path